News

Shareen M. Greenbaum, MD, and Amanda Amberg, OD, recognize comanagement as an opportunity to target dry eye early and use advanced diagnostics and treatments for healthier ocular surfaces.

Neda Gioia, OD, CNS, FMCP, FOWNS, CFMP, details what she finds concerning and surprising in a recent study she conducted with Kaleb Abbott, OD, MS, FAAO, FOWNS.

In this podcast, retina specialist John Kitchens, MD, has a conversation with a patient about the choice he made for anti-VEGF therapy to reduce his treatment burden, then discusses recent clinical trial data on therapeutic options with extended treatment intervals.

Kaleb Abbott, OD, MS, FAAO, FOWNS, details one of his lectures during AOA's Optometry's Meeting 2026.

Jacqueline Theis, OD, FAAO, gave tips to clinicians on how to critically read studies in order to assess if they are applicable to their everyday practice.

Denise Whittam, OD, said that the Acuvue Oasys lens family holds her go-to lenses for patients for their comfortability.

Kaleb Abbott, OD, MS, FAAO, FOWNS, outlined a recent study he conducted with Neda Gioia OD, CNS, IFMCP, FOWNS, on optometry and burnout – in addition to unpublished data on job satisfaction.

Choosing the right patients for soft lenses, orthokeratology, and spectacle lenses has long-lasting effects on the vision health of those with myopia.

FDA clears Lumvoa for active and chronic thyroid eye disease, offering rapid proptosis and diplopia gains—plus key safety monitoring tips.

Erin Rueff, OD, PhD, FAAO, provides an introduction to Johnson & Johnson's versatile contact lens family.

Jacqueline Theis, OD, FAAO, underscored the importance of individualizing care based on where the patient is in their MS journey.

Mark Schaeffer, OD, FAAO, stated that optometrists should be prepared for even the rarest cases of emergencies and urgencies.

ZEISS partners with Envision to expand evidence-backed VR perimetry, enabling more accessible, gamified home visual field testing for glaucoma monitoring.

The resubmission is considered a Class 1 submission and has a current PDUFA target action date of July 29, 2026.

Raman Bhakhri, OD, FAAO, outlines the biomarkers that optometrists should keep in their wheelhouse when examining patients.

Melody Tavakoli, OD, stated that patient complicance remains one of the biggest challenges for contact lens wearers.

Clinical trial data support the Deseyne contact lens, the first FDA-designated EDOF soft contact lens, as a new daily disposable option for presbyopia.

Lori-Ann Christie, PhD, detailed a poster presentation titled "Comparative Analysis of AREDS2 and AREDS2+B Vitamin Complex in an in vitro Model of Age-Related Macular Degeneration."

Will eye drops be an option in the future for keratoconic patients? Clark Chang, OD, MSA, MSc, FAAO, gave us the run-down of what active research may make possible.

Preservative-free bimatoprost gel now offers once-daily glaucoma and ocular hypertension IOP reduction, aiming to boost comfort, tolerability, and long-term adherence.

Mile Brujic, OD, FAAO, stated in a poster presentation that a multi-practice study found that the lens had particularly positive effects on patients who reported dryness symptoms.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, details the challenges of managing dry eye in contact lens wearers via accurate diagnosis and thoughtful lens fitting.

Mitch Ibach, OD, FAAO, said that medication optimization is key when taking the interventional approach to glaucoma.

The emerging technology offers a new paradigm for treating a group of eye diseases.

Joe Shovlin, OD, FAAO, outlines the management and treatment of corneal infections in one of his Optometry's Meeting presentations.

Mohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, discussed his AOA 2026 presentation "Eye of the Needle Returns: Navigating the Patient’s Journey Receiving Intravitreal Injections."

A cross-sectional study of nearly 10,000 nursing home residents found a clear dose-response relationship between vision loss and cognitive impairment, with blind residents having nearly 3 times the odds of cognitive loss compared with those with normal vision.

A Johnson & Johnson Vision poster found a novel multifocal toric daily disposable contact lens delivered visual acuity within 1 letter and comparable fitting success to an existing nontoric multifocal lens, extending coverage to presbyopes with up to 1.75D astigmatism.